Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling
Open Access
- 5 October 2017
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 40 (6) , 1860-1868
Abstract
Human bone marrow‑derived mesenchymal stem cells (hMSCs) are a desirable cell source for cell‑based therapy to treat nervous system injuries due to their ability to differentiate into specific cell types. In addition to their multipotency, hMSCs render the tissue microenvironment more favorable for tissue repair by secreting various growth factors. Our previous study demonstrated that hMSCs secrete several growth factors, including several insulin‑like growth factor binding proteins (IGFBPs). Among these, IGFBP‑6 binds with high affinity and inhibits insulin growth factor‑2 (IGF‑2) to inhibit the growth of IGF‑2‑dependent tumors. However, the function of IGFBP‑6 in the nervous system remains to be fully elucidated. The present study investigated the protective effects of IGFBP‑6 secreted by hMSCs on H2O2‑injured primary cortical neuron cultures and lysolecithin‑injured organotypic spinal cord slice cultures. Treatment of the H2O2‑injured cortical neurons with conditioned media from hMSCs (hMSC‑CM) increased the phosphorylation of Akt, reduced cell death and mitochondrial translocation of Bax, and regulated extracellular levels of IGF‑1 and IGF‑2. MTT assay, western blot analysis and ELISA were used to detect the cell viability and protein expression levels, respectively. An inhibitory antibody against IGFBP‑6 eliminated this hMSC‑CM‑mediated neuroprotective effect in the injured cortical neuron cultures and spinal cord slice cultures. In addition, treatment with cyclolignan picropodophyllin, an inhibitor of IGF‑1 receptor (IGF‑1R), significantly inhibited neuronal protection by hMSC‑CM. These findings demonstrated that hMSC‑CM‑mediated neuroprotection was attributed to IGF‑1R‑mediated signaling, potentiated via the inhibition of IGF‑2 by IGFBP‑6. The results of the present study provide insight into the mechanism by which hMSC administration may promote recovery from nerve injury.Keywords
This publication has 34 references indexed in Scilit:
- Transcriptional Regulation of Serine/Threonine Protein Kinase (AKT) Genes by Glioma-associated Oncogene Homolog 1Journal of Biological Chemistry, 2013
- Characterization of conditioned medium of cultured bone marrow stromal cellsNeuroscience Letters, 2010
- Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic OptionsCurrent Neuropharmacology, 2009
- IGF‐1 protects oligodendrocyte progenitors against TNFα‐induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathwayGlia, 2007
- Gene Expression Profiling Leads to Identification of GLI1-binding Elements in Target Genes and a Role for Multiple Downstream Pathways in GLI1-induced Cell TransformationJournal of Biological Chemistry, 2002
- Mitogenic and Antiapoptotic Effects of Insulin-like Growth Factor Binding Protein-6 in the Human Osteoblastic Osteosarcoma Cell Line Saos-2/B-10Biochemical and Biophysical Research Communications, 1999
- Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic–ischemic injuryMolecular Brain Research, 1998
- Movement of Bax from the Cytosol to Mitochondria during ApoptosisJournal of Cell Biology, 1997
- Cytosol-to-membrane redistribution of Bax and Bcl-XLduring apoptosisProceedings of the National Academy of Sciences, 1997
- Urea-inducible Egr-1 transcription in renal inner medullary collecting duct (mIMCD3) cells is mediated by extracellular signal-regulated kinase activation.Proceedings of the National Academy of Sciences, 1996